News and reflections from the world of AI

    March 22, 2021

    Interview with Dr. Marika Kangasniemi: AI in endometrial cell analysis

    Introduction PEDEGO, a research unit at the University of Oulu, covers a wide range of topics primarily around pediatrics, obstetrics, and gynecology. The metabolic health group within this unit has several ongoing clinical trials related to reproductive and metabolic health in women, including the function of the endometrium in women with polycystic ovary syndrome (PCOS). PCOS affects 10-18% of ...
    Written by Aiforia
    March 16, 2021

    Validation of PD-L1 AI model launches in six labs across the Netherlands

    Introduction Programmed death-ligand 1 (PDL1) is a protein that, when attached to T cells, prevent the immune system from killing cancer cells. Hence, PDL1 is used as a biomarker for tumor immune escape, a sign of increasing cancer progression. PDL1 percentage is also a significant predictor for immunotherapy efficacy, whereby immune checkpoint inhibitors bind to PDL1 and block its ability to ...
    Written by Aiforia
    March 15, 2021

    Aiforia appoints Swedbank as lead advisor to explore financing options

    Aiforia Technologies Oy ("Aiforia" or "the Company") has appointed Swedbank AB (publ) as their lead financial advisor to explore different financing options, including possibilities for an Initial Public Offering (IPO) by listing the Company's shares on Nasdaq Helsinki First North.
    Written by Aiforia
    March 11, 2021

    Interview with Dr. Rish Pai on using AI to study colorectal cancer

    Introduction Colorectal cancer is the third most common cancer in the United States and pathologists are becoming increasingly valuable in the management of these patients. Analysis of histological features of the tumors is the main source of data for diagnosis, but there are many components to this. Routine pathologic assessment does not capture a quantitative view of the extensive variability ...
    Written by Aiforia
    March 2, 2021

    5 things to know about Aiforia 5.0

    We are excited to share our latest software release, bringing Aiforia users increased convenience and confidence in their image analysis! Version 5.0 emphasizes our promise to guarantee security and privacy to researchers, scientists, and pathologists using our software. The latest release is also packed with new enhancements to key features, from image storage to analysis.
    Written by Aiforia
    February 26, 2021

    Case study: AI model for DSS-induced colitis

    Inflammatory Bowel Disease (IBD) is a debilitating disease for which no cure exists. Murine models are widely used to study IBD, amongst them, the DSS-colitis model is a rapid and reliable one. However, the scoring of histopathological lesions is challenging. We interviewed veterinary pathologists at Charles River Laboratories, Dr. Agathe Bedard and Dr. Aleksandra Zuraw, on their recently ...
    Written by Aiforia
    14 15 16 17 18